Showing results (491-500 of 610) with videos related to

Sort By:
Pageof 61
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck CancerEnrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
Genome Medicine|November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivorsS Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2018
Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in MelanomaAras Toker, Linh T Nguyen, Simone C Stone, et al.
Cancer Discovery|July 12, 2022
AACR Project GENIE: 100,000 Cases and BeyondTrevor J Pugh, Jonathan L Bell, Jeff P Bruce, et al.
The Journal of Clinical Investigation|November 1, 2021
Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancerDonghyun D Lee, Martin Komosa, Sumedha Sudhaman, et al.
Nature Communications|July 19, 2022
A brain precursor atlas reveals the acquisition of developmental-like states in adult cerebral tumoursAkram A Hamed, Daniel J Kunz, Ibrahim El-Hamamy, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
The Journal of Head Trauma Rehabilitation|July 17, 2024
Research Letter: Characterizing Lifetime Mild TBI Exposure Among Female and Male Military Service Members and Veterans in the LIMBIC-CENC StudySamuel R Walton, Jessie R Oldham, Rosemay A Remigio-Baker, et al.
Brachytherapy|February 27, 2016
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costingNikhil G Thaker, Thomas J Pugh, Usama Mahmood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor ProgressionStephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
Pageof 61